Advisory Board
Advisory Board
Oliver Sartor, MD
Alton “Oliver” Sartor is director of the newly established Transformational Prostate Cancer Research Center in Louisiana, where he will be responsible for both providing direct patient care and continuing his groundbreaking research, with a primary focus on improving both the longevity and quality of life for men battling prostate cancer. He previously served as Professor of Medical Oncology and Director of Radiopharmaceutical Trials at Mayo Clinic in Rochester, MN, and prior to that as Laborde Professor of Medicine and Urology and Medical Director of the Tulane Cancer Center in New Orleans, LA. An internationally recognized prostate cancer specialist, he earned his MD with honors at Tulane University School of Medicine and completed his training at the University of Pennsylvania, Tulane, and the National Cancer Institute. He subsequently focused his clinical practice and research on prostate malignancies.
Dr Sartor has led or co-led numerous clinical trials, including four pivotal phase III studies that supported US FDA approvals for advanced prostate cancer therapies. His scholarship encompasses more than 500 publications, with significant contributions to the development and evaluation of radiopharmaceutical agents such as radium-223 and lutetium-177 PSMA-targeted treatments. In recognition of his leadership in practice-changing radiopharmaceutical trials, he was named an honorary member of the American Society of Radiation Oncology (ASTRO) in 2023 and has been invited to lecture in at least 33 countries.
